Follow
Julhash U. Kazi
Julhash U. Kazi
Lund University
Verified email at kazilab.se - Homepage
Title
Cited by
Cited by
Year
T cell receptor (TCR) signaling in health and disease
K Shah, A Al-Haidari, J Sun, JU Kazi
Signal transduction and targeted therapy 6 (1), 412, 2021
3672021
FMS-like tyrosine kinase 3/ FLT3: from basic science to clinical implications
JU Kazi, L Rönnstrand
Physiological Reviews 99 (3), 1433–1466, 2019
1732019
SYK is a critical regulator of FLT3 in acute myeloid leukemia
A Puissant, N Fenouille, G Alexe, Y Pikman, CF Bassil, S Mehta, J Du, ...
Cancer cell 25 (2), 226-242, 2014
1552014
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
O Lindblad, E Cordero, A Puissant, L Macaulay, A Ramos, NN Kabir, ...
Oncogene 35 (39), 5119-5131, 2016
1232016
SOCS proteins in regulation of receptor tyrosine kinase signaling
JU Kazi, NN Kabir, A Flores-Morales, L Rönnstrand
Cellular and molecular life sciences 71, 3297-3310, 2014
1162014
Machine learning in the prediction of cancer therapy
R Rafique, SMR Islam, JU Kazi
Computational and Structural Biotechnology Journal 19, 4003-4017, 2021
1122021
Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3
JU Kazi, J Sun, B Phung, F Zadjali, A Flores-Morales, L Rönnstrand
Journal of Biological Chemistry 287 (43), 36509-36517, 2012
792012
Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling
JU Kazi, L Rönnstrand
Molecular oncology 7 (3), 693-703, 2013
612013
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
H Ke, JU Kazi, H Zhao, J Sun
Cell & Bioscience 6, 1-10, 2016
582016
Keratin 19 expression correlates with poor prognosis in breast cancer
NN Kabir, L Rönnstrand, JU Kazi
Molecular biology reports 41, 7729-7735, 2014
532014
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
M Gazi, SA Moharram, A Marhäll, JU Kazi
Cancer letters 392, 9-16, 2017
522017
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
A Hyrenius-Wittsten, M Pilheden, H Sturesson, J Hansson, MP Walsh, ...
Nature Communications 9 (1), 1770, 2018
502018
Brain-Expressed X-linked (BEX) proteins in human cancers
JU Kazi, NN Kabir, L Rönnstrand
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1856 (2), 226-233, 2015
502015
Celecoxib‐induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G
JW Soh, JU Kazi, H Li, WJ Thompson, IB Weinstein
Molecular Carcinogenesis: Published in cooperation with the University of …, 2008
502008
FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia
JU Kazi, L Rönnstrand
Molecular oncology 7 (3), 402-418, 2013
492013
The role of HOXB2 and HOXB3 in acute myeloid leukemia
O Lindblad, RA Chougule, SA Moharram, NN Kabir, J Sun, JU Kazi, ...
Biochemical and biophysical research communications 467 (4), 742-747, 2015
462015
SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
NN Kabir, J Sun, L Rönnstrand, JU Kazi
Tumor Biology 35, 10581-10589, 2014
462014
Phosphorylation-dependent regulation of WNT/beta-catenin signaling
K Shah, JU Kazi
Frontiers in Oncology 12, 858782, 2022
452022
Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3
DC Lin, T Yin, M Koren-Michowitz, LW Ding, S Gueller, S Gery, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3310-3317, 2012
442012
Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling
JU Kazi, L Rönnstrand
PloS one 7 (12), e53509, 2012
402012
The system can't perform the operation now. Try again later.
Articles 1–20